FundedIQ
Biotechnology

Zura Bio: Funding, Investors & Team (Oct 2026)

Zura Bio integrates immunology resources into phase 2 development programs, such as ZB-168 and torudokimab, to provide therapies for patients with autoimmune diseases. ZB-168 is a treatment that targets IL7R and could impact conditions related to IL7 and TSLP pathways. The therapeutic uses of ZB-168 are based on data from phase 1b trials for type 1 diabetes and its profile and biological mechanism. The phase 2 clinical development of torudokimab, a monoclonal antibody that blocks IL33, has also been initiated.

zurabio.com LinkedIn San Diego, United States 11-50 employees
Biopharma Biotechnology Medical
Total raised
$318M
Rounds
3
Latest
Undisclosed round
Feb 2026

Zura Bio has raised $318M across 3 funding rounds on record, the most recent an undisclosed round of $125M announced in Feb 2026.

That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Zura Bio Company Profile and Key Stats

Total funding raised
$318M
across 3 rounds on record
Funding rounds on record
3
Latest funding round
Undisclosed round
$125M in Feb 2026
Employees
11-50
reported band
Headquarters
San Diego, United States

Latest funding round on record: Feb 2026.

Zura Bio Funding Rounds

Date
Round
Amount
Undisclosed round
$125M
Undisclosed round
$113M
Undisclosed round
$80.0M

Zura Bio raised $80.0M in an undisclosed round announced in Apr 2023.

1 years later, an undisclosed round of $113M was announced in Apr 2024.

1.8 years later, an undisclosed round of $125M was announced in Feb 2026.

Zura Bio Founders and Leadership Team

Name
Role
Contact
Chris Cabell
Founder
—
Parisa Faghihi
Founder
—
Someit Sidhu
Founder
—

No contact details are on record for this team yet.

Zura Bio Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M

Zura Bio's latest round of $125M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Zura Bio in Biotechnology and San Diego

Companies Similar to Zura Bio

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Zura Bio Funding FAQs

What does Zura Bio do?

Zura Bio integrates immunology resources into phase 2 development programs, such as ZB-168 and torudokimab, to provide therapies for patients with autoimmune diseases. ZB-168 is a treatment that targets IL7R and could impact conditions related to IL7 and TSLP pathways. The therapeutic uses of ZB-168 are based on data from phase 1b trials for type 1 diabetes and its profile and biological mechanism. The phase 2 clinical development of torudokimab, a monoclonal antibody that blocks IL33, has also been initiated.

How much funding has Zura Bio raised?

Zura Bio has raised $318M across 3 rounds on record. The most recent is an undisclosed round of $125M announced in Feb 2026.

When did Zura Bio last raise funding?

Zura Bio's most recent funding round on record is an undisclosed round of $125M, announced in Feb 2026.

Who founded Zura Bio?

FundedIQ lists Chris Cabell (Founder), Parisa Faghihi (Founder), Someit Sidhu (Founder) at Zura Bio.

Where is Zura Bio headquartered?

Zura Bio is based in San Diego, California, United States.

How many employees does Zura Bio have?

Zura Bio is in the 11-50 employee band.

How does Zura Bio's funding compare to other Biotechnology startups?

Zura Bio's latest round of $125M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Zura Bio Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Zura Bio is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.